James Taylor

James Taylor, Pharm.D., CDE, BCACP

Clinical Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6239
Business Email: jtaylor@cop.ufl.edu

About James Taylor

Dr. Taylor is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research at The University of Florida College of Pharmacy. He received his doctor of pharmacy degree from Ohio Northern University. Upon graduation, he completed an ASHP accredited Pharmacy Practice Residency at The Veterans Affairs Medical Center in Huntington, West Virginia. Subsequently, he completed a Family Medicine Residency at The University of Florida. Dr. Taylor serves as the Director of the Professional Practice Skills Lab series for The UF College of Pharmacy and also coordinates the third year lab courses. He also is responsible for oversight of the third and fourth year OSCEs. Dr. Taylor currently serves as the Pharmacy Director for the UF and Shands Anticoagulation Clinic. In past years he practiced in a family practice clinic and served as residency director for an Ambulatory Care Residency. Dr. Taylor has had an active role in the Laboratory Instructors SIG since 2016, serving as chair of the mentoring and networking committee for the past three years. He has presented at the AACP Annual Meeting on Lab SIG topics as well as lead Lab SIG webinars. He has given numerous other professional presentations on diabetes, anticoagulation and other primary care topics. He has also published extensively on primary care topics and educational topics such as OSCEs. Finally, he has served as Principal Investigator and Co-Principal Investigator for a number of clinical trials. Current research interests include assessing APPE readiness and anticoagulation. Finally, he is a certified diabetes educator and board certified ambulatory care pharmacist.

Research Profile

Comparison of point of care HbA1c monitor versus standard laboratory, Community Health Center at Eastside

Health Literacy Awareness, Community Health Center at Eastside

Clinical Pharmacy PAD Awareness Outreach Program, Community Health Center at Eastside. (grant received in amount of $4500)

Comparison of point of care HbA1c monitor versus standard laboratory, Community Health Center at Eastside

Publications

2020
Ambulatory care elective: Introduction to core practice concepts.
Currents in pharmacy teaching & learning. 12(3):331-338 [DOI] 10.1016/j.cptl.2019.12.013. [PMID] 32273072.
2020
Oral Semaglutide: The First-available Noninjectable Glucagon-like Peptide 1 Receptor Agonist.
Clinical therapeutics. 42(10):2100-2116 [DOI] 10.1016/j.clinthera.2020.07.017. [PMID] 32873415.
2020
Recommendations for integration of foundational and clinical sciences throughout the pharmacy curriculum.
Currents in pharmacy teaching & learning. 12(11):1371-1374 [DOI] 10.1016/j.cptl.2020.06.006. [PMID] 32867937.
2016
Clinical Validation of R-T Estimation for Coaguchek Xs Inr Results
Annals of Pharmacotherapy. 50(8):645-648 [DOI] 10.1177/1060028016647975.
2016
Correction of Point-of-Care INR Results in Warfarin Patients.
Point of care. 15(1):1-3 [PMID] 27103879.
View on: PubMed
2016
Patient Satisfaction With Extended-Interval Warfarin Monitoring
Journal of Thrombosis and Thrombolysis. 42(4):486-493 [DOI] 10.1007/s11239-016-1385-9.
2015
Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists.
Clinical therapeutics. 37(3):483-93 [DOI] 10.1016/j.clinthera.2015.01.003. [PMID] 25659912.
2015
Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin.
Cardiovascular therapeutics. 33(3):98-103 [DOI] 10.1111/1755-5922.12115. [PMID] 25786578.
2014
Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations.
Drugs. 74(18):2141-52 [DOI] 10.1007/s40265-014-0325-2. [PMID] 25414121.
2013
Canagliflozin: a novel treatment option for type 2 diabetes.
Drug design, development and therapy. 7:1399-408 [DOI] 10.2147/DDDT.S48937. [PMID] 24285921.
2013
Insulin analogs for the management of type 2 diabetes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 70(4):320-34 [DOI] 10.2146/ajhp110381. [PMID] 23370139.
2013
Lorcaserin for weight management.
Diabetes, metabolic syndrome and obesity : targets and therapy. 6:209-16 [DOI] 10.2147/DMSO.S36276. [PMID] 23788837.
2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.
Clinical therapeutics. 35(1):A3-17 [DOI] 10.1016/j.clinthera.2012.12.012. [PMID] 23328274.
2012
Teaching clinical problem solving: a preceptor’s guide.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 69(18):1588-99 [DOI] 10.2146/ajhp110521. [PMID] 22935942.
2011
Cranberry phytochemicals inhibit glycation of human hemoglobin and serum albumin by scavenging reactive carbonyls.
Food & function. 2(8):475-82 [DOI] 10.1039/c1fo10087d. [PMID] 21826359.
2011
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
Circulation. 124(13):1452-60 [DOI] 10.1161/CIRCULATIONAHA.111.032920. [PMID] 21900080.
2011
Recent diabetes issues affecting the primary care clinician.
Southern medical journal. 104(6):456-61 [DOI] 10.1097/SMJ.0b013e318213e92b. [PMID] 21886036.
2011
Successful Reorganization of An Interdisciplinary Underserved Practice
Journal of Health Care for the Poor and Underserved. 22:226-231
2010
A New Glucose Monitoring Option
Journal of Family Practice. 59:81-88
2008
Dpp-Iv Inhibitors: a Review of Sitagliptin, Vildagliptin, Alogliptin, and Saxagliptin
Formulary. 43
2007
Diabetes drug update: how 4 new options stack up.
The Journal of family practice. 56(3):207-15 [PMID] 17343811.
View on: PubMed
2007
Home monitoring of glucose and blood pressure.
American family physician. 76(2):255-60 [PMID] 17695570.
View on: PubMed
2006
Pharmacologic management of chronic insomnia.
Southern medical journal. 99(12):1373-7 [PMID] 17233194.
View on: PubMed
2006
Probable interaction between tolterodine and warfarin.
Pharmacotherapy. 26(5):719-21 [PMID] 16718947.
View on: PubMed

Grants

Jul 2014 – Jul 2017
Accuracy of CoaguChek XS in Patients with Antiphospholipid Antibody Syndrome
Role: Principal Investigator
Funding: ROCHE DIAGNOSTICS CORP

Education

Board Certified Ambulatory Care Pharmacist
2015 · Board of Pharmacy Specialties
Certified Diabetes Educator
2003 · National Certification Board for Diabetes Educators
Pharm.D.
1996 · Ohio Northern University

Teaching Profile

Courses Taught
2017-2020
PHA5165L Prof Skills Lab V
2018-2021
PHA5166L Prof Skills Lab Vi
2018,2020
PHA5519 Advanced Topics in Anticoagulation Pharmacotherapy
2018
PHA5763 Ambulatory Care Advanced Pharmacy Practice Experience
2018
PHA5060 Ambulatory Care
2017-2018
PHA5787C Pt Care 5: Endo
2008-2016
PHA5108L Pharmaceu Skls Lab 1
2011,2013-2015
PHA6634 Medication Therapy Management: An Endocrine Focus
2011-2015
PHA5782 Pharmacotherapy 2
2012-2015
PHA5787 Pharmacotherapy 5
2006-2010
PHA5895 Intr Clin Tch in Acad
2006-2008
PHA5783 Pharmacotherapy 3

Contact Details

Phones:
Business:
(352) 273-6239
Emails: